Exploring Novel Treatment Options for Interstitial Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
home / population-health-perspectives / exploring-novel-treatment-options-for-interstitial-pulmonary-fibrosis-and-progressive-pulmonary
nna Podolanczuk, MD, MS, discusses how understanding the risk factors, early diagnosis, and emerging treatment options for interstitial pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) can significantly improve patient outcomes and address critical gaps in current clinical care.
EP. 1: Distinguishing Between the Different Interstitial Lung Diseases
December 13th 2024Anna Podolanczuk, M.D., M.S., discusses how different types of interstitial lung diseases and their main risk factors contribute to the development of idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), as well as how these diseases present with common symptoms and progress over time.
Watch
